Tomohito Kuwako

Tomohito Kuwako

National Hospital Organization - Tokyo / Japan
Others
AD Scientific Index ID: 5105885
国立病院機構
person_outline Tomohito Kuwako's MOST POPULAR ARTICLES
1-) A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations H Imai, K Kaira, K Suzuki, M Anzai, T Tsuda, T Ishizuka, T Kuwako, ... Lung Cancer 126, 41-47, 2018 392018
2-) First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations T Kuwako, H Imai, T Masuda, Y Miura, K Seki, R Yoshino, K Kaira, ... Cancer chemotherapy and pharmacology 76, 761-769, 2015 262015
3-) Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer H Imai, T Kuwako, K Kaira, T Masuda, Y Miura, K Seki, R Sakurai, ... Cancer Chemotherapy and Pharmacology 79, 497-505, 2017 182017
4-) Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutationsT Masuda, H Imai, T Kuwako, Y Miura, R Yoshino, K Kaira, K Shimizu, ...Clinical and Translational Oncology 17, 702-709, 2015182015
5-) Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II studyN Kasahara, N Sunaga, T Kuwako, I Naruse, H Imai, A Jingu, ...Supportive Care in Cancer 28, 4825-4831, 2020162020